Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study

Histopathology

Volumn 60, Issue 3, 2012, Pages 427-436

  Lewis, James S ^a   Khan, Raja A ^a   Masand, Ramya P ^b   Chernock, Rebecca D ^a   Zhang, Qin ^a   Al Naief, Nasser Said ^c   Muller, Susan ^d   Mchugh, Jonathan B ^e   Prasad, Manju L ^f   Brandwein Gensler, Margaret ^g   Perez Ordonez, Bayardo ^h   El Mofty, Samir K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g University of Alabama at Birmingham   (United States)

^h UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Morphology; Nonkeratinizing; Oropharyngeal; P16; Squamous cell carcinoma

Indexed keywords

PROTEIN P16;

ARTICLE; CELL MATURATION; CLINICAL ARTICLE; CLINICAL PRACTICE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONKERATINIZING OROPHARYNX SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; HUMANS; KERATINS; OBSERVER VARIATION; OROPHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF;

HUMAN PAPILLOMAVIRUS;

EID: 84856270666     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04092.x     Document Type: Article

References (43)

1. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44years. Cancer 2005; 103; 1843-1849.
2. Nasman A, Attner P, Hammarstedt L et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int. J. Cancer 2009; 125; 362-366.
3. D'Souza G, Kreimer AR, Viscidi R et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 2007; 356; 1944-1956.
4. Settle K, Posner MR, Schumaker LM et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) 2009; 2; 776-781.
5. Adelstein DJ, Ridge JA, Gillison ML et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck 2009; 31; 1393-1422.
6. Ernster JA, Sciotto CG, O'Brien MM et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papillomavirus. Laryngoscope 2007; 117; 2115-2128.
7. Jung AC, Briolat J, Millon R et al. Biological and clinical relevance of transcriptionnally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int. J. Cancer 2010; 126; 1882-1894.
8. Kumar B, Cordell KG, Lee JS et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J. Clin. Oncol. 2008; 26; 3128-3137.
9. Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2008; 14; 366-369.
10. Hafkamp HC, Manni JJ, Speel EJ. Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol. 2004; 124; 520-526.
11. Ang KK, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2010; 363; 24-35.
12. Lewis JS Jr, Thorstad WL, Chernock RD et al. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am. J. Surg. Pathol. 2010; 34; 1088-1096.
13. Weinberger PM, Yu Z, Haffty BG et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin. Cancer Res. 2004; 10; 5684-5691.
14. Rischin D, Young RJ, Fisher R et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J. Clin. Oncol. 2010; 28; 4142-4148.
15. Fischer CA, Zlobec I, Green E et al. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int. J. Cancer 2010; 126; 1256-1262.
16. Nakahara Y, Shintani S, Mihara M, Ueyama Y, Matsumura T. High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas. Cancer Lett. 2001; 163; 221-228.
17. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int. J. Cancer 2007; 121; 1813-1820.
18. Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. 2008; 100; 261-269.
19. Rich JT, Milov S, Lewis JS Jr, Thorstad WL, Adkins DR, Haughey BH. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope 2009; 119; 1709-1719.
20. Hong AM, Dobbins TA, Lee CS et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br. J. Cancer 2010; 103; 1510-1517.
21. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of Human papillomavirus-associated oropharyngeal cancer. J. Clin. Oncol. 2011; 29; 739-746.
22. El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006; 101; 339-345.
23. Ukpo OC, Pritchett CV, Lewis JE, Weaver AL, Smith DI, Moore EJ. Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients. Ann. Otol. Rhinol. Laryngol. 2009; 118; 368-373.
24. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl Cancer Inst. 2000; 92; 709-720.
25. Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am. J. Pathol. 1998; 152; 145-156.
26. Johnson N, Francheschi S, Ferlay J et al. Squamous cell carcinoma of the oral cavity and oropharynx. In Barnes EL, Eveson JW, Reichart P, Sidransky D eds. World Health Organization Classification of Tumours - Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press, 2005; 168-175.
27. El-Mofty SK, Zhang MQ, Davila RM. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol. 2008; 2; 163-168.
28. Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009; 3; 186-194.
29. Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum. Pathol. 1986; 17; 1158-1166.
30. Masand RP, El-Mofty SK, Ma XJ, Luo Y, Flanagan JJ, Lewis JS Jr. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011; 5; 108-116.
31. Singhi AD, Stelow EB, Mills SE, Westra WH. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma. Am. J. Surg. Pathol. 2010; 34; 800-805.
32. Cardesa A. Spindle cell carcinoma. In Barnes EL, Eveson JW, Reichart P, Sidransky D eds. World Health Organization Classification of Tumours - Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press, 2005; 127-128.
33. Cardesa A, Zidar N, Alos L. Adenosquamous carcinoma. In Barnes EL, Eveson J, Reichart P, Sidransky D eds. World Health Organization Classification of Tumours - Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press, 2005; 130-131.
34. Schlecht NF, Brandwein-Gensler M, Nuovo GJ et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod. Pathol. 2011; 24; 1295-1305.
35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33; 159-174.
36. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam. Med. 2005; 37; 360-363.
37. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J. Clin. Virol. 2005; 32(Suppl. 1); S59-S66.
38. Reimers N, Kasper HU, Weissenborn SJ et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int. J. Cancer 2007; 120; 1731-1738.
39. Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High risk human papillomaviru E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am. J. Surg. Pathol. 2011; 35; 1343-1350.
40. Shi W, Kato H, Perez-Ordonez B et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J. Clin. Oncol. 2009; 27; 6213-6221.
41. Westra W. The changing face of head and neck cancer in the 21st century: the impact of hpv on the epidemiology and pathology of oral cancer. Head Neck Pathol. 2009; 3; 78-81.
42. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am. J. Surg. Pathol. 2008; 32; 1044-1050.
43. Chernock RD, Lewis JS Jr, Zhang Q, El-Mofty SK Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma Hum. Pathol. 2010; 41; 1016-1023.